The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring
Open Access
- 2 May 2015
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 36 (26) , 1640-1642
Abstract
This editorial refers to ‘Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices, by D.T. Martin et al ., doi:10.1093/eurheartj/ehv115 Atrial fibrillation (AF) is the most common clinical arrhythmia, which is responsible for at least 15% of all strokes, and is the leading cause of stroke among patients >75 years old.1 Moreover, strokes due to AF are largely avoidable, as the use of oral anticoagulants (OACs),2,3 along with the diagnosis and treatment of hypertension,4 can prevent >65% of all strokes. The results of large cohort studies in pacemaker patients demonstrate that AF is frequently ‘subclinical’ (either asymptomatic or which evades clinical detection),5,6 suggesting that the true burden of AF in patients over the age of 65 years is much greater than previously appreciated. These studies also show that subclinical AF ( Figure 1 ) is associated with up to a 2.5-fold increase in the risk of stroke,5,7 highlighting the importance of recognizing this condition in patients with pacemakers and implantable cardioverter defibrillators (ICDs). Figure 1 Atrial fibrillation detected by a dual-chamber pacemaker. Martin and colleagues now present the results of the IMPACT trial,8 a 2718 patient, prospective randomized trial that evaluated a strategy to diagnose and manage patients with ICD-detected AF, in patients without contraindications to OACs. Although the patient population was broad and simply defined, the intervention studied by the investigators was quite complex. Patients in the intervention arm of …Keywords
This publication has 15 references indexed in Scilit:
- Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic EventsCirculation, 2014
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Stepwise Screening of Atrial Fibrillation in a 75-Year-Old PopulationCirculation, 2013
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of TRENDSHeart Rhythm, 2011
- Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and StrokeCirculation, 2010
- The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke RiskCirculation: Arrhythmia and Electrophysiology, 2009
- Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohortAmerican Heart Journal, 2009
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991